首页|血清ChE和PA水平变化与慢性阻塞性肺疾病合并呼吸衰竭患者APACHE Ⅱ评分的相关性及临床意义

血清ChE和PA水平变化与慢性阻塞性肺疾病合并呼吸衰竭患者APACHE Ⅱ评分的相关性及临床意义

扫码查看
目的 探讨血清胆碱酯酶(ChE)、前白蛋白(PA)水平变化与慢性阻塞性肺疾病合并呼吸衰竭患者急性生理学和慢性健康状况评价Ⅱ(APACHE Ⅱ)评分的相关性及临床意义.方法 选取2020-05-01-2022-10-31虞城县人民医院收治的196例慢性阻塞性肺疾病患者作为研究对象,根据是否合并呼吸衰竭将患者分为合并组(n=103)和未合并组(n=93),根据住院28 d生存情况将慢性阻塞性肺疾病合并呼吸衰竭患者分为病死(27例)和生存(76例)2个亚组.比较2组入院时血清ChE、PA水平、APACHE Ⅱ评分及血气分析指标[动脉血氧分压(PaO2)、动脉血二氧化碳分压(PaCO2)],比较病死和生存慢性阻塞性肺疾病合并呼吸衰竭患者血清ChE、PA水平(入院时、治疗7 d后、治疗前后差值△),分析血清ChE、PA水平与APACHE Ⅱ评分及血气分析指标的相关性,偏回归分析慢性阻塞性肺疾病合并呼吸衰竭患者预后的影响因素,受试者工作特征(ROC)曲线分析血清△ChE、ΔPA水平联合检测对慢性阻塞性肺疾病合并呼吸衰竭预后的预测价值.结果 入院时合并组血清ChE(3 058.65±418.69)U/L、PA水平(129.58±16.78)mg/L、PaO2(44.58±5.73)mmHg 低于未合并组(5 843.26±489.17)U/L、(204.34±21.56)mg/L、(69.17±4.49)mmHg,PaCO2(62.49±4.78)mmHg、APACHE Ⅱ 评分(34.68±4.15)分高于未合并组(37.44±3.18)mmHg、(21.59±3.67)分,差异有统计学意义,t值分别为42.928、27.227、33.192、42.714、23.189,均P<0.001;治疗7 d后病死患者血清ChE(3 464.29± 358.43)U/L、PA 水平(140.08±15.76)mg/L 低于生存患者(5 246.76±322.84)U/L、(189.36±16.53)mg/L,差异有统计学意义,F值分别为22.449、18.762,均P<0.001;入院时血清ChE、PA水平与PaO2呈正相关,与PaCO2、A-PACHE Ⅱ 评分呈负相关,P<0.05;logistic 回归分析显示,血清△ ChE(>1 720.86 U/L)、ΔPA(>46.86 mg/L)水平是慢性阻塞性肺疾病合并呼吸衰竭患者预后的保护因素,P<0.05;ROC曲线显示,血清ΔChE、ΔPA水平联合预测慢性阻塞性肺疾病合并呼吸衰竭患者预后的曲线下面积(AUC)为0.836,最佳灵敏度、特异度分别为96.30%、71.05%,P<0.05.结论 血清ChE、PA水平在慢性阻塞性肺疾病合并呼吸衰竭患者中呈低表达,动态监测血清水平变化可了解患者病情程度,且联合应用时可有效预测预后效果,可为临床早期防治措施制定提供依据.
Correlation and clinical significance of serum ChE and PA levels with APACHE Ⅱ scores in patients with COPD complicated with respiratory failure
Objective To investigate the correlation and clinical significance of serum cholinesterase(ChE)and prealbumin(PA)levels with acute physiology and chronic health status evaluation Ⅱ(APACHE Ⅱ)score in patients with COPD complicated with respiratory failure.Methods A total of 196 COPD patients admitted to Yucheng People's Hospital from May 1,2020,to October 31,2022,were selected as the study subjects.Patients were divided into a combined group(n=103)and a non-combined group(n=93)based on the presence or absence of respiratory failure.The COPD patients with respiratory failure were further divided into deceased(n=27)and surviving(n=76)subgroups based on their 28-day hospital survival.The serum ChE,PA levels,APACHE Ⅱ scores,and blood gas analysis indicators[arterial oxygen tension(PaO2),arterial carbon dioxide tension(PaCO2)]were compared between the two groups.The serum ChE and PA levels were compared in the deceased and surviving subgroups.The correlation between serum ChE and PA levels,APACHE Ⅱ scores,and blood gas analysis indicators was analyzed.Logistic regression analysis was used to iden-tify factors affecting the prognosis of COPD patients with respiratory failure.The predictive value of serum ΔChE andΔPA levels in the prognosis of COPD patients with respiratory failure was analyzed using receiver operating characteristics(ROC)curves.Results At admission,the levels of ChE(3 058.65±418.69)U/L,PA(129.58±16.78)mg/L,PaO2(44.58±5.73)mmHg in the combined group were lower than those in the non-combined group(5 843.26±489.17)U/L,(204.34±21.56)mg/L,(69.17±4.49)mmHg.The scores of PaCO2(62.49±4.78)mmHg and APACHE Ⅱ(34.68± 4.15)were higher than those of the non-combined group(37.44±3.18)mmHg and(21.59±3.67),with statistically significant differences(t values were 42.928,27.227,33.192,42.714,23.189,all P<0.001);After 7 days of treat-ment,the levels of ChE/L and PA in serum of deceased patients(3 464.29±358.43)U/L and PA(140.08± 15.76)mg/L were lower than those of surviving patients(5 246.76±322.84)U/L and(189.36±16.53)mg/L(F val-ues were 22.449,18.762,all P<0.001).Serum ChE and PA levels at admission were positively correlated with PaO2,but negatively correlated with PaCO2 and APACHE Ⅱ scores(P<0.05).Logistic regression analysis showed that serumΔChE(>1 720.86 U/L)and ΔPA(>46.86 mg/L)levels were protective factors for prognosis of COPD patients with respiratory failure(P<0.05).ROC curve showed that the AUC of serum ΔChE and ΔPA combined to predict the prog-nosis of COPD patients with respiratory failure was 0.836,and the best sensitivity and specificity were 96.30%and 71.05%,respectively(P<0.05).Conclusions Serum ChE and PA levels are low in COPD patients with respiratory fail-ure.Dynamic monitoring of serum level changes can understand the severity of patients'disease,and the combined appli-cation can effectively predict the prognosis,which can provide a basis for the formulation of early clinical prevention and treatment measures.

chronic obstructive pulmonary diseasrespiratory failureacute physiology and chronic health status evaluation Ⅱcholinesteraseprealbumin

张倩、赵敏、马威

展开 >

虞城县人民医院呼吸内科,河南 商丘 476300

河南大学淮河医院呼吸内科,河南开封 475000

慢性阻塞性肺疾病 呼吸衰竭 急性生理学和慢性健康状况评价Ⅱ 胆碱酯酶 前白蛋白

2024

社区医学杂志
中华预防医学会

社区医学杂志

影响因子:0.588
ISSN:1672-4208
年,卷(期):2024.22(7)
  • 30